These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 30268764

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Characteristics, Malignancy Rate, and Follow-up of BI-RADS Category 3 Lesions Identified at Breast MR Imaging: Implications for MR Image Interpretation and Management.
    Chikarmane SA, Birdwell RL, Poole PS, Sippo DA, Giess CS.
    Radiology; 2016 Sep; 280(3):707-15. PubMed ID: 27089027
    [Abstract] [Full Text] [Related]

  • 3. Frequency of Malignancy and Imaging Characteristics of Probably Benign Lesions Seen at Breast MRI.
    Grimm LJ, Anderson AL, Baker JA, Johnson KS, Walsh R, Yoon SC, Ghate SV.
    AJR Am J Roentgenol; 2015 Aug; 205(2):442-7. PubMed ID: 26204298
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement.
    Gutierrez RL, DeMartini WB, Eby PR, Kurland BF, Peacock S, Lehman CD.
    AJR Am J Roentgenol; 2009 Oct; 193(4):994-1000. PubMed ID: 19770321
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. BI-RADS category 3, 4, and 5 lesions identified at preoperative breast MRI in patients with breast cancer: implications for management.
    Lee SE, Lee JH, Han K, Kim EK, Kim MJ, Moon HJ, Yoon JH, Park VY.
    Eur Radiol; 2020 May; 30(5):2773-2781. PubMed ID: 32006168
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characteristics of probably benign breast MRI lesions.
    Eby PR, DeMartini WB, Gutierrez RL, Saini MH, Peacock S, Lehman CD.
    AJR Am J Roentgenol; 2009 Sep; 193(3):861-7. PubMed ID: 19696303
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Breast lesions classified as probably benign (BI-RADS 3) on magnetic resonance imaging: a systematic review and meta-analysis.
    Spick C, Bickel H, Polanec SH, Baltzer PA.
    Eur Radiol; 2018 May; 28(5):1919-1928. PubMed ID: 29168006
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Benign (BI-RADS 2) lesions in breast MRI.
    Spick C, Szolar DH, Tillich M, Reittner P, Preidler KW, Baltzer PA.
    Clin Radiol; 2015 Apr; 70(4):395-9. PubMed ID: 25649442
    [Abstract] [Full Text] [Related]

  • 16. Breast imaging reporting and data system (BI-RADS) lexicon for breast MRI: interobserver variability in the description and assignment of BI-RADS category.
    El Khoury M, Lalonde L, David J, Labelle M, Mesurolle B, Trop I.
    Eur J Radiol; 2015 Jan; 84(1):71-76. PubMed ID: 25454100
    [Abstract] [Full Text] [Related]

  • 17. Can Follow-up be Avoided for Probably Benign US Masses with No Enhancement on MRI?
    Avendano D, Marino MA, Onishi N, Leithner D, Martinez DF, Gibbs P, Jochelson M, Pinker K, Morris EA, Sutton EJ.
    Eur Radiol; 2021 Feb; 31(2):975-982. PubMed ID: 32870394
    [Abstract] [Full Text] [Related]

  • 18. The Value of Lesion Size as an Adjunct to the BI-RADS-MRI 2013 Descriptors in the Diagnosis of Solitary Breast Masses.
    Kawai M, Kataoka M, Kanao S, Iima M, Onishi N, Ohashi A, Sakaguchi R, Toi M, Togashi K.
    Magn Reson Med Sci; 2018 Jul 10; 17(3):203-210. PubMed ID: 29213007
    [Abstract] [Full Text] [Related]

  • 19. Prevalence and Predictive Value of BI-RADS 3, 4, and 5 Lesions Detected on Breast MRI: Correlation with Study Indication.
    Chikarmane SA, Tai R, Meyer JE, Giess CS.
    Acad Radiol; 2017 Apr 10; 24(4):435-441. PubMed ID: 27955878
    [Abstract] [Full Text] [Related]

  • 20. Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up.
    Hambly NM, Liberman L, Dershaw DD, Brennan S, Morris EA.
    AJR Am J Roentgenol; 2011 Jan 10; 196(1):218-24. PubMed ID: 21178070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.